Torimura, Takuji

Publishing since 2004 (Junior)

Has published 15 publications in 4 years

Number of publications published per year by Torimura, Takuji. (Source : PubMed)

Distribution of publications types for Torimura, Takuji. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, Kurogi J, Tajiri N, Inoue K, Niizeki T, Koga H, Imaizumi T, Kojiro M, Sata M. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.  Liver Int.  2007;27;8  
•  Sumie S, Kawaguchi T, Komuta M, Kuromatsu R, Itano S, Okuda K, Taniguchi E, Ando E, Takata A, Fukushima N, Koga H, Torimura T, Kojiro M, Sata M. Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection.  Oncol. Rep.  2007;18;3  
•  Nakamura T, Torimura T, Sakamoto M, Hashimoto O, Taniguchi E, Inoue K, Sakata R, Kumashiro R, Murohara T, Ueno T, Sata M. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model.  Gastroenterology  2007;133;1  
•  Fukushima N, Kuromatsu R, Uchiyama D, Itano S, Takata A, Ando E, Sumie S, Torimura T, Uchida M, Nakashima O, Kojiro M, Sata M. Hyperplastic nodular hepatic lesions following end-to-side portacaval shunting in childhood.  Intern. Med.  2007;46;15  
•  Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, Sumie S, Nagaoka S, Akiyoshi J, Inoue K, Torimura T, Kumashiro R, Ueno T, Sata M. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.  J. Clin. Gastroenterol.  2006;40;10  
•  Nagaoka S, Itano S, Ishibashi M, Torimura T, Baba K, Akiyoshi J, Kurogi J, Matsugaki S, Inoue K, Tajiri N, Takada A, Ando E, Kuromatsu R, Kaida H, Kurogi M, Koga H, Kumashiro R, Hayabuchi N, Kojiro M, Sata M. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.  Liver Int.  2006;26;7  
•  Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, Yano H, Kojiro M, Sata M. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.  Cancer Res.  2006;66;9  
•  Torimura T, Ueno T, Kin M, Taniguchi E, Nakamura T, Inoue K, Sakata R, Hashimoto O, Sakamoto M, Ohira H, Kumashiro R, Sata M, Yano H, Kojiro M, Veitonmaki N, Cao Y. Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.  Gastroenterology  2006;130;4  
•  Taniguchi E, Kin M, Torimura T, Nakamura T, Kumemura H, Hanada S, Hisamoto T, Yoshida T, Kawaguchi T, Baba S, Maeyama M, Koga H, Harada M, Kumashiro R, Ueno T, Mizuno S, Ikeda H, Imaizumi T, Murohara T, Sata M. Endothelial progenitor cell transplantation improves the survival following liver injury in mice.  Gastroenterology  2006;130;2  
•  Hashimoto O, Shinkawa M, Torimura T, Nakamura T, Selvendiran K, Sakamoto M, Koga H, Ueno T, Sata M. Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line.  BMC Cancer  2006;6  

[ See timeline ] [ See all publications ]